BioCentury
ARTICLE | Company News

Roche, AmorChem deal

August 4, 2014 7:00 AM UTC

Roche partnered with VC fund AmorChem to discover small molecules to treat myotonic muscular dystrophy type 1. Discovery will take place at AmorChem’s medicinal chemistry incubator NuChem Therapeutics...